**Company No: 06606603 Charity No: 1129387** 

## **The Sydney Driscoll Neuro-Science Foundation (Company Limited by Guarantee)** 

## **Financial Statements** 

**For The Year Ended 5 April 2021** 



**THE SYDNEY DRISCOLL NEURO-SCIENCE FOUNDATION (COMPANY LIMTED BY GUARANTEE)** 

## **CONTENTS** 

||**Page**|
|---|---|
|Legal and Administrative Information|1|
|Trustees’ Annual Report|2|
|Independent Auditor’s Report to the Members|5|
|Statement of Financial Activities|8|
|Balance Sheet|9|
|Notes to the Financial Statements|10|





**THE SYDNEY DRISCOLL NEURO-SCIENCE FOUNDATION (COMPANY LIMTED BY GUARANTEE)** 

## **COMPANY INFORMATION** 

**Registered Charity Name** The Sydney Driscoll Neuro-Science Foundation **Charity Registration Number** 1129387 **Company Registration Number** 06606603 **Trustees/Directors** J A Ferguson N Gurusinghe J Winnard N D Park **Registered Office** 7 Winckley Square Preston PR1 3JD **Secretary** Mr John Andrew Ferguson **Statutory Auditor** MHA Moore and Smalley Chartered Accountants Richard House 9 Winckley Square Preston PR1 3HP **Solicitors** Napthens 7 Winckley Square Preston PR1 3JD 

-1- 



**THE SYDNEY DRISCOLL NEURO-SCIENCE FOUNDATION (COMPANY LIMITED BY GUARANTEE)** 

## **TRUSTEES’ ANNUAL REPORT** 

## **FOR THE YEAR ENDED 5 APRIL 2021** 

The trustees, who are also directors for the purposes of company law are pleased to present their present their combined directors and trustees’ report and financial statements for the year ended 5 April 2021. 

The financial statements comply with the Charities Act 2011, the Companies Act 2006, the Memorandum and Articles of Association, and Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (October 2019) 

## **Structure, governance and management** 

## **Governing document** 

The charity is a company limited by guarantee, governed by its Memorandum and Articles of Association, and was incorporated on 30 May 2008. 

## **Recruitment and appointment of trustees** 

Trustees are recruited from time to time by the existing trustees on the basis of their knowledge and experience of the administration and delivery of health services fund raising and where it is perceived that they are qualified to deliver other relevant experience and skills to the charity. The trustees are actively seeking to appoint additional suitable directors and trustees. 

## **Trustees induction and training** 

Upon appointment the trustees are generally appraised in meetings of the financial position and the objects of the charity and of relevant ongoing programmes for delivery of these objects. 

## **Organisational structure** 

The board of trustees administers the charity. The trustees who served during the period are set out on page 1. The trustees meet quarterly. 

## **Risk management** 

The trustees have examined the major strategic, business and operational risks which the charity faces and confirm that systems have been established to enable regular reports to be produced so that the necessary steps can be taken to lessen the risks. 

## **Objectives and activities** 

The charity's objects are to heal and relieve sick, disabled and aged persons from the disabilities and infirmities with which they are afflicted in one or more of the following ways: 

- By establishing, fitting out and stocking and maintaining a library specialising in neuro-surgical and neurological medicine and allied neuro-sciences containing books and journals and such auxiliary goods items and equipment, together with the necessary furniture and fixtures and fittings as the trustees in their discretion may consider advisable for the use of medical practitioners. 

- By promoting and funding research and education and generally by developing the practice of neurosurgical and neurological medicine and allied neuro-sciences by such means as the trustees may in their absolute discretion deem to be appropriate and by disseminating for the public benefit any useful results obtained from any research and/or developments. 

- By acquiring or assisting in the acquisition or provision of such plant machinery and equipment as the trustees in their absolute discretion may deem appropriate for use in conjunction with the practice and development of neuro-surgical and neurological medicine and allied neuro-sciences. 

The trustees confirm that they have referred to the guidance contained in the Charity Commission’s general guidance on public benefit when reviewing the charity’s aims and objectives and in planning future activities and setting the grant making policy for the year. 

-2- 



**THE SYDNEY DRISCOLL NEURO-SCIENCE FOUNDATION (COMPANY LIMITED BY GUARANTEE)** 

## **TRUSTEES’ ANNUAL REPORT** 

## **FOR THE YEAR ENDED 5 APRIL 2021** 

## **Achievement and performance** 

The details of the charity’s income and expenditure for the year and its net assets at 5 April 2021 are on pages 8 and 9 of the financial statements. In summary, the charity generated income of £27,376 in the year to fund expenditure of £42,330. 

During the accounting period the trustees have continued their sponsorship of the development and maintenance of a brain tissue bank at the Tissue Culture Laboratory at Royal Preston Hospital and sponsored the SDNF annual award for research papers in neuroscience related work, although the annual SDNF lecture did not proceed because of the Covid pandemic.  They have continued the funding and development of the SDNF Neurosciences Library situated in the neuroscience department at Royal Preston Hospital. The trustees are engaged with The School of Clinical and Biomedical Sciences at The University of Central Lancashire in relation to the sponsorship of a new research project relating to neuro oncology. They have entered into an agreement with the University to contribute £100,000 over a period of three years to a jointly managed scheme for research into treatment of brain cancer. This project has been delayed because of Covid related issues which have affected The University of Central Lancashire personnel but is now proceeding and a series of research projects have been identified which will use the full contribution. 

There are no restrictions on the charity’s power to invest. The investment strategy is reviewed regularly by the trustees and takes account of the demand for funds. Due to the volatility in the investment markets, the trustees were content to hold high levels of cash deposits at 5 April 2021. They are continuing to review this policy and to take advice from their investment advisers, Messrs J M Finn & Co. The trustees will not invest in companies associated with the tobacco industry. 

## **Financial review** 

## **Reserves policy** 

At 5 April 2021 the charity held unrestricted reserves of £830,548.  The trustees have the power to apply both capital and income towards the objects of the Foundation.  The trustees’ current policy and practice is to spend the income and to make up any shortfall required to maintain their sponsorship of approved projects out of capital. They are prepared in appropriate circumstances to make significant grants out of capital towards suitable projects. 

## **Principal funding sources** 

Principal funding sources are the historic endowment received under the will of Mrs Lucille Driscoll and income generated thereon. During the relevant accounting year the trustees have received significant additional grants from patients of Royal Preston Hospital and their families. 

## **Going concern** 

The Trustees have considered the impact of the Government response to Covid-19 on the activity of the charity. The expenditure of the charity is variable with few fixed costs.  Income is not expected to reduce significantly and projects are continuing where possible.  As a result, the Trustees consider that the charity has sufficient reserves to meet liabilities as they fall due for a period of at least twelve months from the date of the signing of the accounts. 

## **Plans for future periods** 

The trustees will continue to meet their objectives in the current year. 

-3- 



THE SYDNEY DRISCOLL NEURO-SCIENCE FOUNDATION
(COMPANY LIMITED BY GUARANTEE)
TRUSTEES, ANNUAL REPORT
FOR THE YEAR ENDED S APRIL 2021
Responslbllltles of the trustees
The Iruslees (who are also directors of th& ¢harlly for the purposes of cornpany18w) are respons6blg for preparlng
the Trustees, Annual Report and the financial slalemenls in accordance with applicable law and Unit8d Kin*om
Accounting Stsndards (United Kingdom Gene¥ally Accepted Accounting Pr8cti¢e}.
Company law requires the Iruslees lo prepare flnancial slalamenls for aach financial year, which give a tru8 and
fair view of the slate of affairs of the charitable company and ol the incoming resourcè$ and applic8tlon of
resources, includlng the Ineomè and expenditure. of the charitable company for that peri(Kl. In preparing Ihese
financial stalemenls, the trustees are required to=
select suitable accounting policies and than apply Iham eonsist8nlly',
observe the methods and principlgs in the Charities SORP 2019 IFRS102)',
make judgements and eslim8tes that are reasonablè and prudènt.,
state whether applicable UK Accounting Standards hav8 been followed. subject lo any material
departures disclosed and explained In the flnanclal statements.,
prepare the financial ytalemgnts on the golng concern basis unles5 11 is inappropriate lo presume that Ihg
charitable Company wlll continue in opeTalion.
The Iruslees are responsible for k8&ping ad8qu8t8 accounting records that disclose with reasonable accuracy al
any time the financial position of the charitable ¢(mP8ny and enable them lo ensure that the linanolal statements
comply with the Cornpani8s Act 2006. They are also responsible for safeguarding th8 assats of the charitabl8
eomp8ny and hance for taking reasonable steps for the prevention and dele¢lion of fraud and other irregularities.
In so far as the trustees are aware..
there is no relevant audit infortnalion t)f whl¢h the charitable cornpany's auditor is unawarè., 8rtd
the Iruslees have taken all steps Ihal they ought lo have laken to make themselves awaré ol any rèlevant
8udil infomiation 8nd to èstablish that the audilor is aware of that information.
Audltors
A ¥esolution to re-appoint MHA Moore and Smalley as audltors forlhe ensuing year will be proposed al Ihe annual
general meetlng In accordance with the Charllies Act 2011.
Signed by order of the trust88s
Mr John Andrew Ferguson
Company Secretary
Reglslored office..
7 Wlnckley Square
P￿StOn
Lancashire
PR13JD
2710112021
Oate..

**THE SYDNEY DRISCOLL NEURO-SCIENCE FOUNDATION (COMPANY LIMITED BY GUARANTEE)** 

## **INDEPENDENT AUDITOR’S REPORT TO THE MEMBERS FOR THE YEAR ENDED 5 APRIL 2021** 

## **Opinion** 

We have audited the financial statements of The Sydney Driscoll Neuro-Science Foundation (the ‘charitable company’) for the year ended 5 April 2021, which comprise the Statement of Financial Activities, the Balance Sheet and the related notes, including significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland (United Kingdom Generally Accepted Accounting Practice). 

In our opinion the financial statements: 

- give a true and fair view of the state of the charitable company’s affairs as at 5 April 2021, and of its incoming resources and application of resources, including its income and expenditure, for the year then ended; 

- have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and 

- have been prepared in accordance with the requirements of the Companies Act 2006. 

## **Basis for opinion** 

We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditor’s responsibilities for the audit of the financial statements section of our report.  We are independent of the charitable company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC’s Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements.  We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion. 

## **Conclusions relating to going concern** 

In auditing the financial statements, we have concluded that the trustees’ use of the going concern basis of accounting in the preparation of the financial statements is appropriate. 

Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the charitable company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue. 

Our responsibilities and the responsibilities of the trustees with respect to going concern are described in the relevant sections of this report. 

## **Other information** 

The trustees are responsible for the other information included in the trustees annual report.  The other information comprises the information included in the trustees’ annual report, other than the financial statements and our auditor’s report thereon.  Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon. 

In connection with our audit of the financial statements, our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the course of the audit or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact. 

We have nothing to report in this regard. 

-5- 



**THE SYDNEY DRISCOLL NEURO-SCIENCE FOUNDATION (COMPANY LIMITED BY GUARANTEE)** 

## **INDEPENDENT AUDITOR’S REPORT TO THE MEMBERS FOR THE YEAR ENDED 5 APRIL 2021** 

## **Opinions on other matters prescribed by the Companies Act 2006** 

In our opinion, based on the work undertaken in the course of the audit: 

- the information given in the trustees’ report (incorporating the directors’ report) for the financial year for which the financial statements are prepared is consistent with the financial statements; and 

- the trustees’’ report has been prepared in accordance with applicable legal requirements. 

## **Matters on which we are required to report by exception** 

In the light of our knowledge and understanding of the charitable company and its environment obtained in the course of the audit, we have not identified material misstatements in the trustees’ report. 

We have nothing to report in respect of the following matters in relation to which the Companies Act 2006 requires us to report to you if, in our opinion: 

- adequate accounting records have not been kept, or returns adequate for our audit have not been received from branches not visited by us; or 

- the financial statements are not in agreement with the accounting records and returns; or 

- certain disclosures of directors’ remuneration specified by law are not made; or 

- we have not received all the information and explanations we require for our audit ; or 

- the trustees were not entitled to prepare the financial statements in accordance with the small companies’ regime take advantage of the small companies’ exemptions in preparing the directors’ report and from the requirement to prepare a strategic report. 

## **Responsibilities of trustees** 

As explained more fully in the trustees’ responsibilities statement set out on page 3 and 4, the trustees (who are also the directors of the charitable company for the purposes of company law) are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the trustees determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error. 

In preparing the financial statements, the trustees are responsible for assessing the charitable company’s ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the trustees either intend to liquidate the charitable company or to cease operations, or have no realistic alternative but to do so. 

## **Auditor’s responsibilities for the audit of the financial statements** 

Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor’s report that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements. 

Irregularities, including fraud, are instances of non-compliance with laws and regulations. We design procedures in line with our responsibilities, outlined above, to detect material misstatements in respect of irregularities, including fraud. The extent to which our procedures are capable of detecting irregularities, including fraud is detailed below: 

-6- 



## **THE SYDNEY DRISCOLL NEURO-SCIENCE FOUNDATION (COMPANY LIMITED BY GUARANTEE)** 

## **INDEPENDENT AUDITOR’S REPORT TO THE MEMBERS** 

## **FOR THE YEAR ENDED 5 APRIL 2021** 

- Obtaining an understanding of the legal and regulatory frameworks that the Charity operates in, focusing on those laws and regulations that have had a direct effect on the financial statements. The key laws and regulations we considered in this context relate to the Charities Act; 

- Discussions with management, including consideration of known or suspected instances of noncompliance with laws and regulations and fraud; 

- Enquiry of management and those charged with governance around actual and potential litigation and claims; 

- Performing audit work over the risk of management override of controls, including, evaluating the business rationale of significant transactions outside the normal course of business and reviewing accounting estimates for bias; 

- Reviewing minutes of meetings of those charged with governance; and 

- Reviewing financial statement disclosures and testing to supporting documentation to assess compliance with applicable laws and regulations. 

Because of the inherent limitations of an audit, there is a risk that we will not detect all irregularities, including those leading to a material misstatement in the financial statements or non-compliance with regulation.  This risk increases the more that compliance with a law or regulation is removed from the events and transactions reflected in the financial statements, as we will be less likely to become aware of instances of non-compliance. The risk is also greater regarding irregularities occurring due to fraud rather than error, as fraud involves intentional concealment, forgery, collusion, omission or misrepresentation. 

A further description of our responsibilities for the audit of the financial statements is located on the Financial Reporting Council’s website at: www.frc.org.uk/auditorsresponsibilities. This description forms part of our auditor’s report. 

## **Use of our report** 

This report is made solely to the charitable company’s trustees, as a body, in accordance with Part 4 of the Charities (Accounts and Reports) Regulations 2008.  Our audit work has been undertaken so that we might state to the charitable company’s trustees those matters we are required to state to them in an auditor’s report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the charitable company and the charitable company’s trustees as a body, for our audit work, for this report, or for the opinions we have formed. 

…………………………. 

## **Nicola Mason (Senior Statutory Auditor) For and on behalf of MHA Moore and Smalley Chartered Accountants & Statutory Auditor** 

Richard House Winckley Square Preston PR1 3HP 04/02/2022 Date: ……………………….. 

-7- 



## **THE SYDNEY DRISCOLL NEURO-SCIENCE FOUNDATION (COMPANY LIMITED BY GUARANTEE)** 

## **STATEMENT OF FINANCIAL ACTIVITIES (INCORPORATING THE INCOME & EXPENDITURE ACCOUNT) FOR THE YEAR ENDED 5 APRIL 2021** 

|**Note**<br>**Income from:**<br>Donations and legacies<br>Investment income<br>Other income<br>**Total incoming resources**<br>**3**<br>**Expenditure on:**<br>Raising funds<br>Charitable activities<br>**Total resources expended**<br>**4**<br>**Net income/(expenditure) before investments**<br>**Net gains / (losses) on investments**<br>**Net income/(expenditure)**<br>**Reconciliation of funds**<br>Balance brought forward at 6 April 2020<br>**Balance carried forward at 5 April 2021**|**Total funds**<br>**for the year**<br>**ended**<br>**5 April**<br>**2021**<br>**£**<br>829<br>26,541<br>6<br>27,376<br>5,417<br>36,913<br>42,330<br>(14,954)<br>147,155<br>132,201<br>698,347<br>830,548|**Total funds**<br>**for the year**<br>**ended**<br>**5 April**<br>**2020**<br>**£**<br>5,082<br>28,928<br>18<br>34,028<br>5,940<br>47,205<br>53,145<br>(19,117)<br>(183,767)<br>(202,884)<br>901,231<br>698,347|
|---|---|---|
||||
||||
||||
||||
||||



All movements in both the current and prior year are in unrestricted funds and relate to continuing activities. 

-8- 



THE SYDNEY DRISCOLL NEURO-SCIENCE FOUNDATION
(COMPANY LIMITED BY GUARANTEE
BALANCE SHEET
AS AT S APRIL 2021
2021
2020
Note
Fixed assets
Investmènts
770,988
623,790
Current assèts
Debtors
Cash al bank
4.265
59.212
4,467
74.411
63,477
78,878
Current Ilabllltlgs
Credilors.. amounts lalling due within
one year
13,9171
14,3211
Net current assets
59,560
74,557
Net assets
830,548
698,347
The fund$ of th? charlty:
Unrestricted
830.548
698.347
Total charlty funds
830.548
698.347
These financial slalemenls were approved and authorised for issue by the Iruslees on
slgned
n their behalf by..
27101121
-and ar
J A Ferguson
Trustee
Company Reglslrallon Number.. 06606603
Thè notes on pages 10 to 14 form part of these fflnanclal slalements.

**THE SYDNEY DRISCOLL NEURO-SCIENCE FOUNDATION (COMPANY LIMITED BY GUARANTEE)** 

## **NOTES TO THE ACCOUNTS FOR THE YEAR ENDED 5 APRIL 2021** 

## 1 **Accounting policies** 

## **Legal form** 

The charity constitutes a limited company, limited by guarantee as defined by the Companies Act 2006, incorporated in England and Wales. The registered office is as stated on page 1.  In the event of the charity being wound up, the liability in respect of the guarantee is limited to £1 per member of the charity. The nature of the charity’s operations and principal activities are in the detailed in the  Report of the Trustees. 

## **Basis of accounting** 

The financial statements have been prepared in accordance with Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland issued in October 2019, the Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland (FRS 102), the Charities Act 2011, the Companies Act 2006 and UK Generally Accepted Accounting Practice. The charity has applied Update Bulletin 1 as published on 2 February 2016 and does not include a cash flow statement on the grounds that it is applying FRS 102 Section 1A. 

The Sydney Driscoll Neuro-Science Foundation meets the definition of a public benefit entity under FRS 102. Assets and liabilities are initially recognised at historical cost or transaction value unless otherwise stated in the relevant accounting policy notes. 

## **Preparation of the accounts on a going concern basis** 

The financial statements have been prepared on a going concern basis and the trustees believe that no material uncertainties exist. The Trustees have considered the impact of the Government response to Covid-19 on the activity of the charity. The expenditure of the charity is variable with few fixed costs. Income is not expected to reduce significantly and projects are continuing where possible.  As a result, the Trustees consider that the charity has sufficient reserves to meet liabilities as they fall due for a period of at least twelve months from the date of the signing of the accounts. 

## **Income** 

Income is recognised in the Statement of Financial Activities on an accruals basis.  Investment income is recognised on an accruals basis. 

## **Resources expended** 

Expenditure, inclusive of VAT, is charged to the Statement of Financial Activities on an accruals basis. 

## **Financial instruments** 

The charity only has financial assets and financial liabilities of a kind that qualify as basic financial instruments. Basic financial instruments are initially recognised at transaction value and subsequently measured at their settlement value. 

## **Investments** 

Investments are stated on the balance sheet at market value.  Unrealised gains and losses, and gains and losses on disposal are recorded in the Statement of Financial Activities. 

## **Cash at bank and in hand** 

Cash at bank includes cash held by the administrator, investment manager and banks. 

## **Accruals** 

Accruals are recognised where the charity has a present obligation resulting from a past event that will probably result in the transfer of funds to a third party and the amount due to settle the obligation can be measured or estimated reliably. These are normally recognised at their settlement amount. 

-10- 



**THE SYDNEY DRISCOLL NEURO-SCIENCE FOUNDATION (COMPANY LIMITED BY GUARANTEE)** 

## **NOTES TO THE ACCOUNTS** 

## **FOR THE YEAR ENDED 5 APRIL 2021** 

## 1 **Accounting policies (continued)** 

## **Books** 

Expenditure on books and periodicals is written off in the accounting period in which this is incurred. 

## **Fund accounting** 

Unrestricted funds can be used in accordance with the charitable objectives at the discretion of the trustees. Restricted funds can only be used for particular restricted purposes within the objects of the charity.  Restrictions arise when specified by the donor or when funds are raised for particular restricted purposes. 

Further explanation of the nature and purpose of each funds is included in the notes to the financial statements. 

## **2 Judgements and key sources of estimation uncertainty** 

There have been no significant judgements (apart from those involving estimates) made in the process of preparing the accounts.  There have been no key assumptions concerning the future and other key sources of estimation uncertainty at the reporting date that have a significant risk of causing a material adjustment to the carrying amounts of assets and liabilities within the next financial year. 

## **3 Incoming resources** 

|**Incoming resources**|||
|---|---|---|
||**Year ended**|**Year ended**|
||**5 April**|<br>**5 April**|
||**2021**|**2020**|
||**£**|**£**|
|**_Donations and legacies_**|||
|Donations|829|5,082|
|**_Investment income_**|||
|M & G Investments Charifund|12,462|16,133|
|CCLA Investments COIF|43|305|
|Blackrock Asset Management Charinco|11,513|9,044|
|Glaxosmithkline Ordinary shares|1,880|1,880|
|BP Ordinary shares|201|324|
|BMO Commercial Property Trust|442|1,242|
||26,541|28,928|
|**_Other income_**|||
|Bank interest|6|18|
||27,376|34,028|



-11- 



**THE SYDNEY DRISCOLL NEURO-SCIENCE FOUNDATION (COMPANY LIMITED BY GUARANTEE)** 

## **NOTES TO THE ACCOUNTS FOR THE YEAR ENDED 5 APRIL 2021** 

## **4 Resources expended** 

|**_Charitable activities_**<br>**Direct costs**<br>Project funding<br>Library services<br>Lecture fees and expenses<br>**Support costs**<br>Insurance<br>Accounting and administration fees<br>Web hosting<br>Bank charges<br>Sundry expenses<br>Admin Fee<br>Governance - Auditor’s remuneration (inclusive of VAT)<br>**_Total charitable activities_**<br>**_Cost of raising funds_**<br>Investment management charges|**Year ended**<br>**5 April**<br>**2021**<br>**£**<br>19,100<br>-<br>4,603<br>23,703<br>1,046<br>4,590<br>-<br>52<br>634<br>5,000<br>1,888<br>13,210<br>36,913<br>5,417<br>42,330|**Year ended**<br>**5 April**<br>**2020**<br>**£**<br>23,222<br>6,105<br>10,165|**Year ended**<br>**5 April**<br>**2020**<br>**£**<br>23,222<br>6,105<br>10,165|
|---|---|---|---|
||||39,492|
||||1,000<br>4,657<br>-<br>95<br>197<br>-<br>1,764|
||||7,713|
||||47,205<br>5,940|
||||53,145|



Project funding comprises: £19,100 Lancashire Teaching Hospitals (institution). 

|||**2021**|**2020**|
|---|---|---|---|
|||**£**|**£**|
|Auditor’s remunerations consists of the following charges:||||
|-|Audit of the financial statements (exclusive of VAT)|1,544|1,470|



-12- 



**THE SYDNEY DRISCOLL NEURO-SCIENCE FOUNDATION (COMPANY LIMITED BY GUARANTEE)** 

## **NOTES TO THE ACCOUNTS FOR THE YEAR ENDED 5 APRIL 2021** 

## **5 Investments** 

|M & G Investments<br>Charifund<br>Blackrock Asset<br>Management<br>Charinco<br>CCLA investments<br>COIF Charities<br>BMO Commercial<br>Property Trust<br>Glaxosmithkline<br>Ordinary Shares<br>BP Ordinary Share|**Market**<br>**value at**<br>**6 April**<br>**2020**<br>£<br>221,763<br>296,205<br>51,647<br>15,801<br>35,001<br>3,373<br>623,790|**Additions**<br>£<br>-<br>-<br>-<br>-<br>-<br>-<br>-|**Sales**<br>**proceeds**<br>£<br>-<br>-<br>-<br>-<br>-<br>-<br>-|**Change in**<br>**value**<br>£<br>62,636<br>89,373<br>-<br>598<br>(4,977)<br>(475)<br>147,156|**Market**<br>**value at**<br>**5 April**<br>**2021**<br>£<br>284,399<br>385,578<br>51,690<br>16,399<br>30,024<br>2,898<br>770,988|**Cost at**<br>**5 April**<br>**2021**<br>£<br>188,249<br>168,910<br>13,000<br>23,000<br>31,439<br>6,202<br>430,800|
|---|---|---|---|---|---|---|



The aggregate amount of listed investments at 5 April 2021 was £32,922 (2020: £38,374). The aggregate amount of cash and cash equivalents at 5 April 2021 was £51,690 (2020: £51,647). 

## **6 Debtors** 

|**Debtors**|||
|---|---|---|
||**Year ended**|**Year ended**|
||**5 April**|<br>**5 April**|
||**2021**|**2020**|
||**£**|**£**|
|Prepayments and accrued income|4,265|4,467|
|**Creditors: amounts falling due within one year**|||
||**Year ended**|**Year ended**|
||**5 April**|<br>**5 April**|
||**2021**|**2020**|
||**£**|**£**|
|Accruals|3,917|4,321|



## **7 Creditors: amounts falling due within one year** 

-13- 



**THE SYDNEY DRISCOLL NEURO-SCIENCE FOUNDATION (COMPANY LIMITED BY GUARANTEE)** 

## **NOTES TO THE ACCOUNTS** 

## **FOR THE YEAR ENDED 5 APRIL 2021** 

## **8 Trustees’ remuneration, trustees’ expenses and remuneration paid to key management personnel** 

None of the trustees received any remuneration or expenses during the current or previous year. 

The charity had no paid key management personnel during the current or previous year. 

## **9 Financial commitments** 

Approximately eight years ago the Foundation agreed on an informal basis to contribute approximately £12,400 to fund work at Royal Preston Hospital to extend and refurbish the neuroscience library.  This work has been carried out by the Lancashire Teaching Hospital Trust which has not followed up the matter of this contribution and it is now considered unlikely that it will do so. 

The Foundation entered into an agreement in 2019 with the University of Central Lancashire to contribute £100,000 over a period of three years to a jointly managed scheme for research into treatment of brain cancer. This project has been delayed because of Covid related issues which have affected The University of Central Lancashire personnel but is now proceeding and a series of research projects have been identified which will use the full contribution. 

## **10 Taxation** 

The Foundation is a registered charity and consequently there is no liability to taxation on income derived from its charitable activities. 

## **11 Financial instruments** 

|**Financial instruments**|||
|---|---|---|
||**2021**|**2020**|
||**£**|**£**|
|**Carrying amount of financial assets**|||
|Measured at fair value through net income/expenditure|770,988|623,790|



-14-